drugset / Trial / NCT02252809

Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects

NCT02252809

Phase 0 Completed 51 enrolled Brugmann University Hospital
RandomizedParallel-groupOpen-labelBasic science

Summary

The main objective of this study is to characterize the biological responses elicited by endotoxin inhalation applied to healthy subjects, and to assess the effect of standard anti-inflammatory agents (i.e. adalimumab and methylprednisolone) on these biological responses.

Timeline

Start
2008-11
Primary completion
2009-04
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adalimumab Monoclonal antibody 40 mg Subcutaneous
Comparator Methylprednisolone Other / unclassified 20 mg Oral

Indications

No indication recorded.